Compare LCID & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCID | BIRK |
|---|---|---|
| Founded | 2007 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 6.1B |
| IPO Year | 2020 | 2023 |
| Metric | LCID | BIRK |
|---|---|---|
| Price | $9.40 | $34.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | $19.67 | ★ $62.69 |
| AVG Volume (30 Days) | ★ 5.1M | 2.1M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $595,271,000.00 | N/A |
| Revenue This Year | $70.41 | $13.71 |
| Revenue Next Year | $92.93 | $14.21 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.97 | $33.06 |
| 52 Week High | $25.22 | $57.39 |
| Indicator | LCID | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 37.69 |
| Support Level | $9.38 | $33.06 |
| Resistance Level | $10.78 | $42.19 |
| Average True Range (ATR) | 0.53 | 1.56 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 0.33 | 20.50 |
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.